Cannabis Digest

In the United Kingdom, employers are mandated to extend their existing duty of care and health and safety obligations to employees who are prescribed medical cannabis, treating it no differently than any other legally prescribed medication. This approach ensures fairness and compliance with established legal frameworks, particularly the Equality Act 2010 and the Health and Safety at Work Act 1974, rather than requiring the creation of separate, potentially discriminatory policies.

The landscape of medical cannabis use is evolving globally, and the UK, having legalised medical cannabis prescriptions in 2018, is no exception. As more individuals receive prescriptions for debilitating conditions such as chronic pain, employers face the critical task of integrating these patients into the workforce without prejudice. The core principle, as highlighted by experts, is that existing legal duties are sufficient when applied thoughtfully and without stigma.

Many patients prescribed medical cannabis in the UK manage severe, often life-limiting conditions. For these individuals, their prescription is a vital part of their health management. Employers, therefore, must recognise that their responsibilities towards these employees mirror those owed to any other staff member with a medical condition requiring treatment.

The legal framework in the UK provides clear guidelines for employers regarding employee health and disability. The Equality Act 2010 prohibits discrimination based on protected characteristics, which includes disability. Many conditions for which medical cannabis is prescribed, such as chronic pain, can meet the Act's definition of a disability, depending on the individual's circumstances and the long-term impact on their daily activities. Alongside this, the Health and Safety at Work Act 1974 places a general duty on employers to ensure, so far as is reasonably practicable, the health, safety, and welfare of their employees.